Siemens Medical Systems has ceded responsibility for global cyclotronsales and marketing to its PET partner, Computer Technology Imaging(CTI) of Knoxville, TN. The move enables Siemens to focus on marketingits PET products, according to Thomas Cafarella,
Siemens Medical Systems has ceded responsibility for global cyclotronsales and marketing to its PET partner, Computer Technology Imaging(CTI) of Knoxville, TN. The move enables Siemens to focus on marketingits PET products, according to Thomas Cafarella, group vice presidentof Siemens' nuclear medicine unit in Hoffman Estates, IL.
Siemens acquired marketing rights to CTI's PET scanner and RadioisotopeDelivery System (RDS) cyclotron through an investment and marketingagreement in 1987 (SCAN 11/25/87). Siemens will continue to handlesales and support of the ECAT PET line and will arrange for CTIsupport of cyclotron service contracts currently in place.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.